Summary: MAPS-sponsored researcher Bruce Poulter, M.P.H., joins the Keep Talking Podcast to discuss his interest in MDMA-assisted therapy, a patient’s experience of receiving such therapy, and MAPS’ …
Summary: MAPS Founder and Executive Director Rick Doblin, Ph.D., sits down with Aubrey Marcus to explain MAPS’ multiple research, policy, and education priorities in the context of our larger, long-term …
Summary: MAPS Founder and Executive Director Rick Doblin, Ph.D., joins the Long Now Seminars Podcast to discuss the transformational potential of MDMA-assisted therapy for PTSD. “MDMA is more about …
Summary: MAPS Founder and Executive Director Rick Doblin, Ph.D., joins Oteil Burbridge and Mike Finoia on the Comes a Time Podcast for an expansive conversation primarily focused on psychedelics, though …
Summary: “I started this work when I was 18,” reflects MAPS Founder and Executive Director Rick Doblin, Ph.D. “I’m now 67, and we’re still not there. ‘There’ meaning …
After four years, MAPS Founder and Executive Director Rick Doblin, Ph.D., returns to the David Pakman Show to provide an update about the state of psychedelic research, including the results of MAPS’ …
Summary: MAPS Founder and Executive Director Rick Doblin, Ph.D., joins the Lex Fridman Podcast to discuss the history of psychedelic substances in culture and research, the ways in which MAPS is working …
Summary: MAPS Founder and Executive Director Rick Doblin, Ph.D., joins FOX News Radio’s Kennedy Saves the World Podcast to explain the results of MAPS’ first Phase 3 clinical trial investigating …
Summary: At a virtual event held to celebrate the legacy of psychedelic pioneers Alexander “Sasha” Shulgin and Ann Shulgin, MAPS Founder and Executive Director Rick Doblin, Ph.D., participated …
Summary: “When I started MAPS in 1986, I knew I wanted to use the word ‘psychedelic’ in the title,” recalls MAPS Founder and Executive Director Rick Doblin, Ph.D. “Even though …
Summary: MAPS Founder and Executive Director Rick Doblin, Ph.D., and Roland Griffiths, Ph.D., Founding Director of the Johns Hopkins Center for Psychedelic and Consciousness Research, join WYPR Baltimore’s …
Summary: Berra Yazar-Klosinski, Ph.D., of MAPS and MAPS Public Benefit Corporation (MAPS PBC) joins Nick Jikomes, Ph.D., on the Good Chemistry podcast to discuss how and why MDMA-assisted therapy is utilized …
